TheStreet.com |
Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Biogen
TheStreet.com Roche (RHHBY) won U.S. approval Tuesday for a new, long-acting drug to treat multiple sclerosis that is expected to deliver billions of dollars in sales to the Swiss pharma giant while potentially cutting into Biogen's (BIIB) core business. The Roche ... New MS Drug Ocrevus Wins FDA Approval Roche MS drug Ocrevus approved by FDA after three-month delay FDA Approves Genentech's OCREVUS™ (Ocrelizumab) for Relapsing and Primary Progressive Forms of Multiple ... |
from Health - Google News http://ift.tt/2nyyJHS
EmoticonEmoticon